Cargando…
Substance use disorders among older adults: A review of randomized controlled pharmacotherapy trials
Substance use disorders (SUDs) are a growing problem among older adults. Acamprosate, disulfiram, and naltrexone are United States Food and Drug Administration (referred to as FDA) approved for the treatment of alcohol use disorder, and buprenorphine is approved for the treatment of opiate use disor...
Autores principales: | Tampi, Rajesh R, Chhatlani, Aarti, Ahmad, Hajra, Balaram, Kripa, Dey, Joel, Escobar, Ricardo, Lingamchetty, Thejasvi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757194/ https://www.ncbi.nlm.nih.gov/pubmed/31559148 http://dx.doi.org/10.5498/wjp.v9.i5.78 |
Ejemplares similares
-
Pimavanserin for the treatment of psychosis in Alzheimer’s disease: A literature review
por: Srinivasan, Shilpa, et al.
Publicado: (2020) -
Pharmacotherapy for Insomnia Disorder in Older Adults
por: Grandner, Michael A., et al.
Publicado: (2019) -
Minding the brain: the role of pharmacotherapy in substance-use disorder treatment
por: Elias, Dakwar, et al.
Publicado: (2017) -
Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020) -
Pharmacotherapy of post-traumatic stress disorder: going beyond the guidelines
por: Davidson, Jonathan
Publicado: (2016)